SMARCA4 and adrenal cortex carcinoma: While one might consider the possibility of primary adrenal SMARCA4-deficient undifferentiated tumors, comprehensive genomic characterization and immunohistochemical feature of adrenocortical carcinomas have not revealed alterations in the SMARCA4 gene (17).